Umbilical cord-derived mesenchymal stem/stromal cells (UC-MSCs) emerge as a
perspective for therapeutic use in immune and inflammatory diseases. Indeed …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …

Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …

Background COVID-19 is a multisystem disease that presents acute and persistent
symptoms, the postacute sequelae (PASC). Long-term symptoms may be due to …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …

The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

During the pandemic of severe respiratory distress syndrome coronavirus 2 (SARS-CoV2),
many novel therapeutic modalities to treat Coronavirus 2019 induced disease (COVID-19) …

The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

Background Treatment of acute respiratory distress syndrome (ARDS) associated with
COronaVIrus Disease-2019 (COVID-19) currently relies on dexamethasone and supportive …

Background The long-term consequences of human umbilical cord-derived mesenchymal
stem cell (UC-MSC) treatment for COVID-19 patients are yet to be reported. This study …